Spotlight Therapeutics

3953 Point Eden Way
United States

Show jobs for this employer

About Spotlight Therapeutics

Spotlight Therapeutics is a venture funded early-stage biotechnology company with a mission to develop a new class of therapeutics by enabling direct in vivo gene editing. Founded by Alex Marson (UCSF), Jacob Corn (UZH), and Patrick Hsu (UC-Berkeley) in December of 2017, Spotlight is building its core technology platform to achieve precise in vivo gene editing in targeted cell populations, expanding CRISPR therapeutic applications and patient access.  

4 articles about Spotlight Therapeutics